Home / United Kingdom / Hikma Pharmaceuticals Public Limited Company
Hikma Pharmaceuticals Public Limited Company
Short position disclosed on July 1, 2026.
0.79% of the capital sold short
? funds not named
13 disclosures on record
GB00B0LCW083 ISIN code
Since 13 July 2026 this regulator publishes an aggregated total per company and no longer names the funds. Positions disclosed before that date remain nominative.
Funds holding Hikma Pharmaceuticals Public Limited Company Titelia
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Jul 10Jul 19Jul 28Aug 6
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Aggregated total | 0.79% | unchanged | July 1, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 5, 2026 | Aggregated total | 1.01% | August 6, 2026 |
| August 4, 2026 | Aggregated total | 1.50% | August 5, 2026 |
| July 29, 2026 | Aggregated total | 1.70% | August 4, 2026 |
| July 28, 2026 | Aggregated total | 1.90% | July 29, 2026 |
| July 27, 2026 | Aggregated total | 2.22% | July 28, 2026 |
| July 23, 2026 | Aggregated total | 2.02% | July 27, 2026 |
| July 22, 2026 | Aggregated total | 2.75% | July 23, 2026 |
| July 21, 2026 | Aggregated total | 2.94% | July 22, 2026 |
| July 20, 2026 | Aggregated total | 3.23% | July 21, 2026 |
| July 17, 2026 | Aggregated total | 3.69% | July 20, 2026 |
| July 14, 2026 | Aggregated total | 3.56% | July 17, 2026 |
| July 9, 2026 | Aggregated total | 3.69% | July 14, 2026 |
| July 1, 2026 | Aggregated total | 0.79% | still open |
Other companies sold short in the United Kingdom
- Ibstock PLC 20.90% of the capital sold short
- Vistry Group PLC 20.08% of the capital sold short
- Capita PLC 13.92% of the capital sold short
- Chemring Group PLC 11.71% of the capital sold short
- WH Smith PLC 11.69% of the capital sold short
- Wizz Air Holdings PLC 11.60% of the capital sold short
- Genuit Group PLC 11.12% of the capital sold short
- Crest Nicholson Holdings PLC 11.01% of the capital sold short
- Ceres Power Holdings PLC 10.80% of the capital sold short
- Greggs PLC 10.50% of the capital sold short
- R&S Group Holding AG 10.11% of the capital sold short
- Breedon Group Plc 9.96% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Hikma Pharmaceuticals Public Limited Company, source FCA, data as at July 1, 2026, https://www.quivad.com/action/hikma-pharmaceuticals-public-limited-company